about
Development of an HbA1c-based conversion equation for estimating glycated albumin in a Korean population with a wide range of glucose intoleranceAnatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011)The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population.Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure.The roles of glycated albumin as intermediate glycation index and pathogenic protein.Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness.Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study.Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.A case of hypoglycemic brain injuries with cortical laminar necrosis.Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice.Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study).Enhanced gene transfer to pancreatic islets using glucagon-like peptide-1.Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus.Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017.Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease.SGLT2 inhibitor regulates ketone body metabolism via inter-organ crosstalkNonalcoholic Fatty Liver Disease and Diabetes: Part II: TreatmentComparison of Renal Effects of Ezetimibe-Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched AnalysisThe Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-AnalysisEffectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-AnalysisGlycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney DiseaseIpragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled TrialA Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 InhibitorEffectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without SulfonylureaGamma glutamyltransferase and risk of dementia in prediabetes and diabetesSGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular diseaseNon-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
P50
Q28538120-3C943985-AC47-4F8B-866B-868780D6ABB3Q33604348-D59BE4A4-1CE7-4156-966F-C1CC131AFAA7Q35656400-3D5E763E-6E29-4F73-AC92-C7BF3422C67CQ35911068-DD787088-5DFA-4CBB-9F13-F2644193718CQ35911117-49D9DB20-94C0-453E-A8AD-3247356C737CQ37482466-040F3E41-E871-4BAB-8550-CF0EFF93A82CQ37583052-5CFF665D-8CC7-4A76-A3D3-E252728800D5Q40438828-2114FA1B-8F38-4C69-ACDB-D8B03045C74DQ40774837-AB765827-9128-4404-B211-6A0CA078A1A7Q42633689-1B8A4481-3ABE-4A60-BCCC-04AC711BAC28Q43187617-1870471D-4946-489F-9D1A-AF39D32F8410Q45885780-FA8009B1-A6FC-4863-8F6C-79B136AFF829Q46087999-0204622C-6915-4232-AF6D-63CCDC10053BQ47142499-9B4CFFEF-D657-4E6E-80E9-F511AB380D11Q47768810-9E41A460-5F4A-40D4-AB75-7FEEE30CEBE4Q48320286-9C7EB42E-5850-4493-8EC5-5A5C517F7FE0Q55418964-E3287A12-D4E5-4946-A23B-B978B7791789Q58578882-A0F907C2-048A-4FBD-9F00-E0A2A2509BD0Q64113047-E356698C-C29B-43D4-9E93-A09B6962D835Q90400249-3A6C7171-795E-4ABE-A8D4-B44191CEAB4BQ90633391-C3BED147-A5C9-4253-88ED-A2AAEA83014BQ90860427-E100E7CF-5225-4969-920D-8BB4C83B2257Q90972121-1CA76C2C-1CA6-4B80-8632-4EB315CEFDE0Q92813444-C35B1385-22BB-4577-AC17-0B2E8AF480EFQ93008518-9E2DE14A-4584-4504-A4C9-C71C9AFF1BA0Q93008530-FFA0BD59-2A76-48F1-80C0-455120E29017Q93163654-AD38095A-55F3-42E2-A709-3CD590B41BCAQ94483947-7A76C2D1-685E-4874-B78E-44F3C1A7D254Q95283692-18AEEBE0-484D-4215-92FB-243AC78C1AC3
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Byung-Wan Lee
@ast
Byung-Wan Lee
@en
Byung-Wan Lee
@es
Byung-Wan Lee
@nl
type
label
Byung-Wan Lee
@ast
Byung-Wan Lee
@en
Byung-Wan Lee
@es
Byung-Wan Lee
@nl
prefLabel
Byung-Wan Lee
@ast
Byung-Wan Lee
@en
Byung-Wan Lee
@es
Byung-Wan Lee
@nl
P31
P496
0000-0002-9899-4992